The enigma of quality of life in patients with heart failure

International Journal of Cardiology

Volumn 125, Issue 3, 2008, Pages 407-409

  Dobre, Daniela ^a   de Jongste, Mike J L ^a   Haaijer Ruskamp, Flora M ^a   Sanderman, Robbert ^a   van Veldhuisen, Dirk J ^a   Ranchor, Adelita V ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Drug therapy; Heart failure; Quality of life

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; INOTROPIC AGENT; PIPERANOMETOZINE; VALSARTAN;

ARTICLE; CLINICAL TRIAL; DEVICE THERAPY; DISEASE COURSE; DRUG MEGADOSE; FOLLOW UP; HEART FAILURE; HUMAN; MEDICAL ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT DURATION; TREATMENT RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOTONIC AGENTS; HEART FAILURE; HUMANS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 40949145278     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.01.044     Document Type: Article

References (17)

1. Testa M.A., and Simonson D.C. Assessment of quality of life outcomes. N Engl J Med 334 (1996) 835-840
2. Hobbs F.D.R., Kenkre J.E., Roalfe A.K., Davis C., Hare R., and Davies M.K. Impact of heart failure and left ventricular systolic dysfunction on quality of life. Eur Heart J 23 (2002) 1867-1876
3. Rector T.S., Kubo S.H., and Cohn J.N. Patients'self-assessment of their congestive heart failure. Part 2: Content, reliability and validity of a new measure, The Minnesota Living with Heart Failure questionnaire. Heart Fail 3 (1987) 198-209
4. Wiklund I., Lindvall K., Swedberg K., and Zupkis R.V. Self-assessment of quality of life in severe heart failure. Scand J Psychol 28 (1987) 220-225
5. Rogers W.J., Johnstone D.E., Yusuf S., et al. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the studies of left ventricular dysfunction. J Am Coll Cardiol 23 (1994) 393-400
6. Wiklund I., and Swedberg K. Some methodological problems in analyzing quality of life data in severe congestive heart failure patients. Clin Res Pharmacoepidemiol 5 (1991) 265-273
7. Majani G., Giardini A., Opasich C., et al. Effect of Valsartan on quality of life when added to usual therapy for heart failure: results from the Valsartan heart failure trial. J Card Fail 11 (2005) 253-259
8. Dobre D., Van Jaarsveld C.H.M., De Jongste M.J.L., Haaijer-Ruskamp F.M., and Ranchor A.V. The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf 16 (2007) 152-159
9. Hall S.A., Cigarroa C.G., Marcoux L., Risser R.C., Grayburn P.A., and Eichhorn E.J. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol 25 (1995) 1154-1161
10. Riegel B., Moser D.K., Glaser D., et al. The Minnesota Living with Heart Failure questionnaire: sensitivity to differences and responsiveness to intervention intensity in a clinical population. Nurse Res 51 (2002) 209-218
11. MERIT-HF Study Group. Effects of controlled-released metoprolol on total mortality, hospitalizations, and well-being in patients with Heart Failure. JAMA 283 (2000) 1295-1302
12. Wiklund I., Waagstein F., Swedberg K., and Hjalmarsson A. Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from MDC trial. Metoprolol in dilated cardiomyopathy trial. Cardiovasc Drugs Ther 10 (1996) 361-368
13. Cohn J.N., Goldstein S.O., Greenberg B.H., et al. A dose-dependent increase in mortality with Vesnarinone among patients with severe heart failure. N Engl J Med 339 (1998) 1810-1816
14. Rector T.S., Tschumperlin L.K., Kubo S.H., et al. Using the living with heart failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail 1 (1995) 201-206
15. Cleland J.G.F., Daubert J.-C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 139-149
16. McAlister F.A., Lawson F.M., Teo K.K., and Armstrong P.W. A systematic review of randomized trials of disease management programs in heart failure. Am J Med 110 (2001) 378-384
17. Van Jaarsveld C.H.M., Sanderman R., Miedema I., Ranchor A.V., and Kempen G.I. Changes in health-related quality of life in older patients with acute myocardial infarction or congestive heart failure: a prospective study. J Am Geriatr Soc 49 (2001) 1052-1058